Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rosenstock J et al. - The study shows no evidence of a greater risk of the development or progression of diabetic retinopathy with insulin glargine vs NPH insulin treatment in patients with type 2 diabetes mellitus.

Related Articles

Glyceraldehyde 3 phosphate dehydrogenase in retinal microvasculature: Implications for the development and progression of diabetic retinopathy
Investigative Ophthalmology and Visual Science, 11/18/09    Relevance Score: 69%

Identification of independent risk factors for the development of diabetic retinopathy requiring treatment
Acta Ophthalmologica, 11/18/09    Relevance Score: 69%

Diabetic Retinopathy Screening Update
Clinical Diabetes, 10/19/09    Relevance Score: 69%

Retinopathy - screening recommendations
Australian Family Physician, 10/06/09    Relevance Score: 69%

Micronutrients and Diabetic Retinopathy: A Systematic Review
Ophthalmology, 11/10/09    Relevance Score: 67%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address